Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region

<b>Background</b>: Ceftazidime–avibactam (CAZ-AVI) is recommended as first-line treatment for Oxacillinase-48 (OXA-48) β-Lactamase-producing carbapenem-resistant Enterobacterales (CRE) infections, while polymyxin-based combination therapies (PBCTs) are used as a last resort when CAZ-AVI is unavailab...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rıdvan Dumlu, Meyha Şahin, Okan Derin, Özlem Gül, Sedef Başgönül, Rehile Zengin, Çiğdem Arabacı, Funda Şimşek, Serap Gençer, Ayşe Sesin Kocagöz, Ali Mert
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-10-01
coleção:	Antibiotics
Assuntos:	ceftazidime–avibactam polymyxins OXA-48 carbapenem-resistant enterobacterales blood stream infections mortality
Acesso em linha:	https://www.mdpi.com/2079-6382/13/10/990
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!